Relationship Between Dopamine Genetics, Food Reinforcement, Energy Intake and Obesity
NCT ID: NCT00962117
Last Updated: 2012-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
310 participants
OBSERVATIONAL
2008-02-29
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Food Reinforcement, Weight Status, and Energy Density
NCT03981172
Decision-making and Food Intake
NCT07133529
Brain Response to Dietary Interventions
NCT02637271
Effect of High-fat/High-sugar Diet on Food Reward Signaling
NCT05574660
Psychological Mechanisms Linking Food Insecurity and Obesity
NCT03441594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese/Non-obese
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-50 years of age
* No known eating disorder
* Moderate liking for study foods
* No current diagnosis of psychiatric disorder (e.g., anxiety or depression)
* Not on medications that would interfere with appetite (e.g., methylphenidate) or dopaminergic activity
* Non-diabetics
Exclusion Criteria
* Pregnant women
* Current diagnosis of a psychiatric or eating disorder
* Dietary restrictions that would interfere with participation
* On medications that could interfere with appetite or olfactory responsiveness or use of antidepressants or any medication or dietary supplement that could affect appetite or dopaminergic activity
* Excessive use of alcohol (\>21 drinks/week), alcoholism,current addiction to opiates, cocaine or stimulants
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York at Buffalo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leonard Epstein
SUNY Distinguished Professor of Pediatrics and Social and Preventive Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonard H Epstein, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
SUNY Buffalo
References
Explore related publications, articles, or registry entries linked to this study.
Lin H, Carr KA, Fletcher KD, Epstein LH. Food reinforcement partially mediates the effect of socioeconomic status on body mass index. Obesity (Silver Spring). 2013 Jul;21(7):1307-12. doi: 10.1002/oby.20158. Epub 2013 Jun 11.
Epstein LH, Carr KA, Lin H, Fletcher KD, Roemmich JN. Usual energy intake mediates the relationship between food reinforcement and BMI. Obesity (Silver Spring). 2012 Sep;20(9):1815-9. doi: 10.1038/oby.2012.2. Epub 2012 Jan 13.
Epstein LH, Lin H, Carr KA, Fletcher KD. Food reinforcement and obesity. Psychological moderators. Appetite. 2012 Feb;58(1):157-62. doi: 10.1016/j.appet.2011.09.025. Epub 2011 Oct 8.
Epstein LH, Carr KA, Lin H, Fletcher KD. Food reinforcement, energy intake, and macronutrient choice. Am J Clin Nutr. 2011 Jul;94(1):12-8. doi: 10.3945/ajcn.110.010314. Epub 2011 May 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1066937-1-44786
Identifier Type: -
Identifier Source: secondary_id
1066937
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.